Robust estimation of the effect of an exposure on the change in a continuous outcome.

Box-Cox transformation Conditional probit model Normal errors Random effects model

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
06 06 2020
Historique:
received: 20 02 2020
accepted: 21 05 2020
entrez: 8 6 2020
pubmed: 9 6 2020
medline: 25 6 2021
Statut: epublish

Résumé

The change in two measurements of a continuous outcome can be modelled directly with a linear regression model, or indirectly with a random effects model (REM) of the individual measurements. These methods are susceptible to model misspecifications, which are commonly addressed by applying monotonic transformations (e.g., Box-Cox transformation) to the outcomes. However, transforming the outcomes complicates the data analysis, especially when variable selection is involved. We propose a robust alternative through a novel application of the conditional probit (cprobit) model. The cprobit model analyzes the ordered outcomes within each subject, making the estimate invariant to monotonic transformation on the outcome. By scaling the estimate from the cprobit model, we obtain the exposure effect on the change in the observed or Box-Cox transformed outcome, pending the adequacy of the normality assumption on the raw or transformed scale. Using simulated data, we demonstrated a similar good performance of the cprobit model and REM with and without transformation, except for some bias from both methods when the Box-Cox transformation was applied to scenarios with small sample size and strong effects. Only the cprobit model was robust to skewed subject-specific intercept terms when a Box-Cox transformation was used. Using two real datasets from the breast cancer and inpatient glycemic variability studies which utilize electronic medical records, we illustrated the application of our proposed robust approach as a seamless three-step workflow that facilitates the use of Box-Cox transformation to address non-normality with a common underlying model. The cprobit model provides a seamless and robust inference on the change in continuous outcomes, and its three-step workflow is implemented in an R package for easy accessibility.

Sections du résumé

BACKGROUND
The change in two measurements of a continuous outcome can be modelled directly with a linear regression model, or indirectly with a random effects model (REM) of the individual measurements. These methods are susceptible to model misspecifications, which are commonly addressed by applying monotonic transformations (e.g., Box-Cox transformation) to the outcomes. However, transforming the outcomes complicates the data analysis, especially when variable selection is involved. We propose a robust alternative through a novel application of the conditional probit (cprobit) model.
METHODS
The cprobit model analyzes the ordered outcomes within each subject, making the estimate invariant to monotonic transformation on the outcome. By scaling the estimate from the cprobit model, we obtain the exposure effect on the change in the observed or Box-Cox transformed outcome, pending the adequacy of the normality assumption on the raw or transformed scale.
RESULTS
Using simulated data, we demonstrated a similar good performance of the cprobit model and REM with and without transformation, except for some bias from both methods when the Box-Cox transformation was applied to scenarios with small sample size and strong effects. Only the cprobit model was robust to skewed subject-specific intercept terms when a Box-Cox transformation was used. Using two real datasets from the breast cancer and inpatient glycemic variability studies which utilize electronic medical records, we illustrated the application of our proposed robust approach as a seamless three-step workflow that facilitates the use of Box-Cox transformation to address non-normality with a common underlying model.
CONCLUSIONS
The cprobit model provides a seamless and robust inference on the change in continuous outcomes, and its three-step workflow is implemented in an R package for easy accessibility.

Identifiants

pubmed: 32505178
doi: 10.1186/s12874-020-01027-6
pii: 10.1186/s12874-020-01027-6
pmc: PMC7275496
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

145

Subventions

Organisme : Clinician Scientist Award-Senior Investigator Category, National Medical Research Council
ID : NMRC/CSA-SI/0015-2017
Pays : International
Organisme : NUS SSHSPH Research Programme - Breast Cancer Prevention Programme
ID : R-608-000-124-733
Pays : International
Organisme : NUS Asian Breast Cancer Research Fund
ID : N-176-000-023-091
Pays : International
Organisme : National Medical Research Council Centre Grant (CG) Programme
ID : CGAug16M005
Pays : International
Organisme : Swedish Cancer Society (Cancerfonden)
ID : CAN 2015/493
Pays : International
Organisme : Centre for Health Services and Policy Research, the National University Health Systems Pte Ltd
ID : SBRO14/NS01G
Pays : International
Organisme : National Medical Research Council of Singapore
ID : clinician scientist award scheme
Pays : International

Références

PLoS One. 2016 Jul 15;11(7):e0159312
pubmed: 27419853
Stat Methods Med Res. 2020 Feb;29(2):437-454
pubmed: 30943882
Stat Methods Med Res. 2019 Apr;28(4):1105-1125
pubmed: 29278142
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
J Diabetes Sci Technol. 2007 Jan;1(1):62-71
pubmed: 19888382
Biochem Med (Zagreb). 2014;24(2):199-210
pubmed: 24969913
Can Vet J. 2009 Jun;50(6):665-8
pubmed: 19721789
Stat Med. 2017 Nov 30;36(27):4316-4335
pubmed: 28872693
Diabetes Metab J. 2015 Aug;39(4):273-82
pubmed: 26301188

Auteurs

Yilin Ning (Y)

NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 21 Lower Kent Ridge, Singapore, 119077, Singapore.
Yong Loo Lin School of Medicine, Department of Surgery, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.

Nathalie C Støer (NC)

Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, PO box 4950, Nydalen, 0424, Oslo, Norway.

Peh Joo Ho (PJ)

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Tahir Foundation Building, Singapore, 117549, Singapore.
Genome Institute of Singapore, 60 Biopolis St, Singapore, 138672, Singapore.

Shih Ling Kao (SL)

Yong Loo Lin School of Medicine, Department of Medicine, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.
University Medicine Cluster, Division of Endocrinology, National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.

Kee Yuan Ngiam (KY)

Yong Loo Lin School of Medicine, Department of Surgery, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Tahir Foundation Building, Singapore, 117549, Singapore.
University Surgical Cluster, Division of General Surgery (Thyroid and Endocrine Surgery), National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.
National University Health System Corporate Office, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.

Eric Yin Hao Khoo (EYH)

Yong Loo Lin School of Medicine, Department of Medicine, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.
University Medicine Cluster, Division of Endocrinology, National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.

Soo Chin Lee (SC)

Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Dr, Singapore, 117599, Singapore.
Department of Haematology-Oncology, National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.

E-Shyong Tai (ES)

Yong Loo Lin School of Medicine, Department of Medicine, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.
University Medicine Cluster, Division of Endocrinology, National University Health System, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore.

Mikael Hartman (M)

NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 21 Lower Kent Ridge, Singapore, 119077, Singapore.
Yong Loo Lin School of Medicine, Department of Surgery, National University of Singapore and National University Health System, 10 Medical Dr, Singapore, 117597, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Tahir Foundation Building, Singapore, 117549, Singapore.

Marie Reilly (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, SE-171 77, Stockholm, Sweden.

Chuen Seng Tan (CS)

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Tahir Foundation Building, Singapore, 117549, Singapore. ephtcs@nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH